Symptoms include intellectual disability, epilepsy, insomnia, and brain MRI abnormalities, and rodent models of Galnt2 knockout also displayed neurologic abnormalities consistent with a functional role of Galnt2-mediated glycosylation in the brain. This evidence concerns the gene GALNT2 and epilepsy.